Cytokines associated with prolonged Cytopenia after axicabtagene ciloleucel in patients with refractory large B-cell lymphoma

被引：1
|
作者：
Strati, Paolo [1 ]
Puebla-Osorio, Nahum [1 ]
Han, Guangchun [1 ]
Westin, Jason [1 ]
Nastoupil, Loretta [1 ]
Samaniego, Felipe [1 ]
Fowler, Nathan [1 ]
Fayad, Luis [1 ]
Lee, Hun Ju [1 ]
Flowers, Christopher [1 ]
Srour, Samer [1 ]
Watson, Grace [1 ]
Wang, Linghua [1 ]
Green, Michael [1 ]
Neelapu, Sattva [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2049
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cytopenia following axicabtagene ciloleucel (axi-cel) for refractory large B-cell lymphoma (LBCL).
    Logue, Jennifer Marilyn
    Krivenko, Gabriel S.
    Larson, Victoria
    Bachmeier, Christina A.
    Chavez, Julio C.
    Davila, Marco L.
    Khimani, Farhad
    Lazaryan, Aleksandr
    Liu, Hien D.
    Pinilla-Ibarz, Javier
    Shah, Bijal D.
    Dholaria, Bhagirathbhai R.
    Jain, Michael D.
    Locke, Frederick Lundry
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Predictors of Cytopenia after Treatment with Axicabtagene Ciloleucel in Patients with Large Cell Lymphoma
    Panaite, Lorena
    Gauthier, Jordan
    Perkins, Paula
    Voutsinas, Jenna
    Wu, Qian Vicky
    Kirk, Angela
    Cearley, Aisling
    Mullane, Erin
    Cassaday, Ryan D.
    Kiem, Hans-Peter
    Chow, Victor A.
    Lynch, Ryan C.
    Ujjani, Chaitra S.
    Smith, Stephen D.
    Gopal, Ajay K.
    Till, Brian G.
    Turtle, Cameron J.
    Maloney, David G.
    Shadman, Mazyar
    BLOOD, 2020, 136
  • [3] Axicabtagene Ciloleucel in Large B-Cell Lymphoma
    Zhao, Wei-Li
    Wu, De-pei
    Hu, Yu
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12): : 1152 - 1153
  • [4] Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma
    Nath, Karthik
    Wudhikarn, Kitsada
    Alarcon Tomas, Ana
    Perales, Miguel-Angel
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (01) : 5 - 15
  • [5] Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
    Grana, Allison
    Gut, Natalia
    Williams, Kiersten
    Maakaron, Joseph
    Porter, Kyle
    William, Basem M.
    Vasu, Sumithira
    Penza, Sam
    Brammer, Jonathan E.
    Saad, Ayman
    Puto, Marcin
    Jaglowski, Samantha M.
    Roddy, Julianna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : 238 - 245
  • [6] Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
    Jallouk, Andrew P.
    Gouni, Sushanth
    Westin, Jason
    Feng, Lei
    Mistry, Haleigh
    Steiner, Raphael E.
    James, Jinsu
    Noorani, Mansoor
    Horowitz, Sandra
    Puebla-Osorio, Nahum
    Fayad, Luis E.
    Iyer, Swaminathan P.
    Hawkins, Misha
    Flowers, Christopher R.
    Ahmed, Sairah
    Nastoupil, Loretta J.
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Neelapu, Sattva S.
    Nieto, Yago
    Strati, Paolo
    HAEMATOLOGICA, 2023, 108 (04) : 1163 - 1167
  • [7] Prophylactic corticosteroid use with axicabtagene ciloleucel in patients with relapsed/refractory large B-Cell lymphoma
    Oluwole, Olalekan O.
    Bouabdallah, Krimo
    Munoz, Javier
    De Guibert, Sophie
    Vose, Julie M.
    Bartlett, Nancy L.
    Lin, Yi
    Deol, Abhinav
    McSweeney, Peter A.
    Goy, Andre H.
    Kersten, Marie Jose
    Jacobson, Caron A.
    Farooq, Umar
    Minnema, Monique C.
    Thieblemont, Catherine
    Timmerman, John M.
    Stiff, Patrick
    Avivi, Irit
    Tzachanis, Dimitrios
    Kim, Jenny J.
    Bashir, Zahid
    McLeroy, Jeff
    Goyal, Lovely
    Johnson, Lisa
    Zheng, Yan
    van Meerten, Tom
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 147 - 148
  • [8] Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
    Westin, Jason R.
    Oluwole, Olalekan O.
    Kersten, Marie Jose
    Miklos, David B.
    Perales, Miguel-Angel
    Ghobadi, Armin
    Rapoport, Aaron P.
    Sureda, Anna
    Jacobson, Caron A.
    Farooq, Umar
    van Meerten, Tom
    Ulrickson, Matthew
    Elsawy, Mahmoud
    Leslie, Lori A.
    Chaganti, Sridhar
    Dickinson, Michael
    Dorritie, Kathleen
    Reagan, Patrick M.
    McGuirk, Joseph
    Song, Kevin W.
    Riedell, Peter A.
    Minnema, Monique C.
    Yang, Yin
    Vardhanabhuti, Saran
    Filosto, Simone
    Cheng, Paul
    Shahani, Shilpa A.
    Schupp, Marco
    To, Christina
    Locke, Frederick L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 148 - 157
  • [9] Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma
    Panaite, Lorena
    Wu, Qian Vicky
    Voutsinas, Jenna
    Mullane, Erin
    Chow, Victor A.
    Lynch, Ryan C.
    Ujjani, Chaitra S.
    Smith, Stephen D.
    Gopal, Ajay K.
    Poh, Christina
    Iovino, Lorenzo
    Turtle, Cameron J.
    Maloney, David G.
    Till, Brian G.
    Gauthier, Jordan
    Shadman, Mazyar
    LEUKEMIA & LYMPHOMA, 2022, 63 (12) : 2918 - 2922
  • [10] Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy
    Spiegel, Jay Y.
    Dahiya, Saurabh
    Jain, Michael D.
    Tamaresis, John
    Nastoupil, Loretta J.
    Jacobs, Miriam T.
    Ghobadi, Armin
    Lin, Yi
    Lunning, Matthew
    Lekakis, Lazaros
    Reagan, Patrick
    Oluwole, Olalekan
    McGuirk, Joseph
    Deol, Abhinav
    Goy, Andre
    Vu, Khoan
    Andreadis, Charalambos
    Munoz, Javier
    Bennani, N. Nora
    Vose, Julie M.
    Dorritie, Kathleen A.
    Neelapu, Sattva S.
    Locke, Frederick L.
    Rapoport, Aaron P.
    Hill, Brian T.
    Miklos, David B.
    BLOOD, 2021, 137 (13) : 1832 - 1835
12345